Healthcare -
Biotechnology - NASDAQ - US
$ 7.37
3.08 %
$ 365 M
Market Cap
-1.47
P/E
RGNX - SHORT-TERM INVESTMENTS
Short-term Investments RGNX - REGENXBIO Inc.
241 M
LAST VALUE
46.46%
2 YEAR CAGR
-0.29%
5 YEAR CAGR
0.00%
10 YEAR CAGR